martes, 26 de noviembre de 2019

After Celgene buy, Bristol-Myers CEO ducks questions about rival - STAT

After Celgene buy, Bristol-Myers CEO ducks questions about rival - STAT

Cancer Briefing

Having gobbled up Celgene, the Bristol-Myers CEO ducks questions about his key rival

By ED SILVERMAN


EMILIE PICKERING FOR STAT
“I think we’re just at the beginning of a long journey," said Bristol-Myers Squibb chief executive Giovanni Caforio about having acquiring Celgene.

No hay comentarios: